Key result
The metabolic syndrome significantly predicted the development of hypertension over a median of 6.4 years (HR 1.89; 95% CI 1.41-2.54 according to NCEP criteria).
Why the study?
Does the metabolic syndrome predict the development of hypertension in a normotensive population?
Cohort (n=1,944)
Does the metabolic syndrome predict the development of hypertension in a normotensive population?
Hazard Ratio: 1.89 (95% CI 1.41–2.54)
Metabolic syndrome is a significant predictor of incident hypertension, particularly in individuals with optimal baseline blood pressure.
Authors
No takes yet. Share an insight, caveat, or question.
Metabolic syndrome may predict incident hypertension; leaves open its role in risk stratification pending confirmatory trials.
Cheung et al. (2007) conducted a cohort in Hypertension (n=1,944). Metabolic syndrome vs. Absence of metabolic syndrome was evaluated on Development of hypertension (HR 1.89, 95% CI 1.41-2.54). The metabolic syndrome significantly predicted the development of hypertension over a median of 6.4 years (HR 1.89; 95% CI 1.41-2.54 according to NCEP criteria).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: